+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Fungal Testing Kits Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 181 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5977799
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The fungal testing kits market is undergoing rapid advancement as senior decision-makers seek robust diagnostic tools to safeguard operations and enable swift, data-driven decisions. This evolving industry is shaped by increasing technology adoption, shifting regulatory landscapes, and sector-specific needs.

Market Snapshot: Fungal Testing Kits Market Size and Growth Drivers

Within the global fungal testing kits market, notable expansion is defining the competitive environment. The market is currently valued at USD 2.88 billion in 2024 and is projected to reach USD 3.12 billion by 2025, with a compound annual growth rate (CAGR) of 8.14% expected to drive revenues toward USD 5.40 billion by 2032. Accelerated growth stems from rising awareness regarding fungal infections, stricter compliance measures, and application across a diverse set of industries, from clinical diagnostics to food safety and industrial processes. Regional variations continue to influence commercial strategies, with leaders in North America, EMEA, Latin America, and Asia-Pacific adapting to changing supply chains, increased competition, and the integration of diagnostic advancements.

Scope & Segmentation: Fungal Testing Kits Market Coverage

This report offers a structured overview for executives to support strategic investment and operational planning in the fungal testing kits sector. Key segmentations include product types, technologies, applications, end-user groups, distribution models, geographic reach, and market participants:

  • Product Types: Culture-based solutions (liquid and solid media), immunoassays such as enzyme-linked immunosorbent assay and lateral flow assay, advanced molecular diagnostics including loop mediated isothermal amplification, next generation sequencing, and polymerase chain reaction formats.
  • Technology Platforms: Conventional and real time PCR, enzyme-linked immunosorbent assay, loop mediated isothermal amplification, and mass spectrometry platforms like matrix-assisted laser desorption ionization time of flight.
  • Applications: Clinical diagnostics in inpatient and outpatient settings, environmental monitoring (air, soil, water), food safety initiatives covering dairy, meat, and produce, and pharmaceutical quality assurance for raw ingredients and finished formulations.
  • End Users: Consumers, hospital laboratories, reference labs, and independent testing facilities, covering a broad landscape of users from public health to industrial sectors.
  • Distribution Channels: Direct organization sales, agreements with distributors, and online procurement channels that facilitate market access and operational efficiency.
  • Geographic Coverage: Major markets in the Americas (including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (such as United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), and Asia-Pacific (spanning China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
  • Company Profiles: Examines key operators including bioMérieux SA, F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Hologic, Inc., Meridian Bioscience, Inc., Luminex Corporation, and DiaSorin S.p.A.

Key Takeaways for Senior Decision-Makers

  • Adoption of advanced molecular diagnostics and emerging spectrometry platforms is redefining industry benchmarks for precision, facilitating prompt, high-confidence results essential in medical and industrial workflows.
  • Integration of digital workflow systems, such as laboratory information management and process automation, is enhancing scalability and operational consistency.
  • Strategic alliances—including joint ventures and selective mergers—are expanding service portfolios, allowing organizations to address a broader array of market verticals and adapt to evolving client needs.
  • Market growth continues into environmental, food safety, and pharmaceutical arenas, translating to improved risk control and new revenue opportunities beyond traditional clinical applications.
  • Regional response strategies prioritize regulatory adaptation and operational maturity, emphasizing tailored compliance for sustained performance and accuracy in reporting results.

Tariff Impact on Fungal Testing Kits Supply Chains

Recent US-imposed tariffs on components and reagents have driven organizations to modify supply chain strategies. Methods such as nearshoring, expanding local manufacturing partnerships, and diversifying sourcing are contributing to stable distribution. Vertically integrated enterprises achieve greater cost certainty and process oversight. Enhanced regulatory collaboration and localized investments further insulate operations, allowing for continuity and supporting ongoing market development.

Methodology & Data Sources

Report findings are grounded in direct interviews with laboratory, procurement, and policy professionals, supported by systematic secondary research. Source materials include peer-reviewed studies, regulatory information, and corporate disclosures to ensure robust quantitative analysis and credible scenario evaluation.

Why This Report Matters

  • Delivers actionable strategic insights for executive teams to drive technology adoption and optimize positioning in the fungal testing kits market.
  • Enables effective risk mitigation through analysis of regulatory, procurement, and supply dynamics across global regions.
  • Supports competitive benchmarking and strategic planning by examining operational trends, innovation, and market approaches among leading industry players.

Conclusion

Ongoing advancement in the fungal testing kits market will depend on adaptive strategy, operational streamline, and a commitment to innovation. Continuous attention to regulatory trends and emerging technologies remains vital for resilient market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Rising adoption of smartphone-enabled at-home fungal infection test kits for early detection
5.2. Integration of rapid PCR-based fungal detection assays into point-of-care diagnostic workflows for healthcare facilities
5.3. Growing demand for eco-friendly reagents in environmental fungal contamination testing to reduce lab waste
5.4. Expansion of multiplex mycotoxin screening test panels enabling quantification of multiple toxins in a single assay
5.5. Adoption of microfluidic lab-on-chip platforms for portable and high-throughput fungal pathogen detection
5.6. Increase in regulatory standards requiring routine mold testing in commercial building air quality monitoring programs
5.7. Use of AI-driven image analysis to automate species identification in clinical and environmental fungal testing
5.8. Collaboration between biotech startups and medical device manufacturers for innovative handheld fungal diagnostic tools
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Fungal Testing Kits Market, by Product Type
8.1. Culture Based
8.1.1. Liquid Media
8.1.2. Solid Media
8.2. Immunoassay
8.2.1. Enzyme Linked Immunosorbent Assay
8.2.2. Lateral Flow Assay
8.3. Molecular
8.3.1. Loop Mediated Isothermal Amplification
8.3.2. Next Generation Sequencing
8.3.3. Polymerase Chain Reaction
8.3.3.1. Conventional
8.3.3.2. Real Time
9. Fungal Testing Kits Market, by Technology
9.1. Conventional Polymerase Chain Reaction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Loop Mediated Isothermal Amplification
9.4. Matrix Assisted Laser Desorption Ionization Time Of Flight
9.5. Real Time Polymerase Chain Reaction
10. Fungal Testing Kits Market, by Application
10.1. Clinical Diagnostics
10.1.1. Inpatient
10.1.2. Outpatient
10.2. Environmental Testing
10.2.1. Air
10.2.2. Soil
10.2.3. Water
10.3. Food Safety
10.3.1. Dairy
10.3.2. Meat
10.3.3. Produce
10.4. Pharmaceutical Quality Control
10.4.1. Active Pharmaceutical Ingredient
10.4.2. Finished Product Testing
11. Fungal Testing Kits Market, by End User
11.1. Consumers
11.2. Hospital Laboratories
11.3. Independent Testing Laboratories
11.4. Reference Laboratories
12. Fungal Testing Kits Market, by Distribution Channel
12.1. Direct Sales
12.2. Distributors
12.3. Online Channels
13. Fungal Testing Kits Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Fungal Testing Kits Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Fungal Testing Kits Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. bioMérieux SA
16.3.2. F. Hoffmann-La Roche AG
16.3.3. Abbott Laboratories
16.3.4. Thermo Fisher Scientific Inc.
16.3.5. Becton, Dickinson and Company
16.3.6. Bio-Rad Laboratories Inc.
16.3.7. Hologic, Inc.
16.3.8. Meridian Bioscience, Inc.
16.3.9. Luminex Corporation
16.3.10. DiaSorin S.p.A.

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Fungal Testing Kits market report include:
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • Luminex Corporation
  • DiaSorin S.p.A.

Table Information